These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 2576270)

  • 1. Quantitative gas chromatographic-mass spectrometric analysis of acrivastine and a metabolite in human plasma.
    Chang SY; Nelson FR; Findlay JW; Taylor LC
    J Chromatogr; 1989 Dec; 497():288-95. PubMed ID: 2576270
    [No Abstract]   [Full Text] [Related]  

  • 2. Quantification of antihistamine acrivastine in plasma by solid-phase extraction and high-performance liquid chromatography.
    Collins BR; Gu X
    J Pharm Biomed Anal; 2007 Jan; 43(1):293-7. PubMed ID: 16930917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and validation of a liquid chromatography-tandem mass spectrometry method for the simultaneous determination of acrivastine and pseudoephedrine in human plasma and its application in pharmacokinetics.
    He JC; Feng EF; Liu M; Li HL; Tian M; Zhang Q; Dong LC; Xu GL
    Arzneimittelforschung; 2012 Oct; 62(10):449-56. PubMed ID: 22936420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacodynamic and pharmacokinetics of BW 825C: a new antihistamine.
    Cohen AF; Hamilton MJ; Liao SH; Findlay JW; Peck AW
    Eur J Clin Pharmacol; 1985; 28(2):197-204. PubMed ID: 2859204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pseudoephedrine and triprolidine in plasma and breast milk of nursing mothers.
    Findlay JW; Butz RF; Sailstad JM; Warren JT; Welch RM
    Br J Clin Pharmacol; 1984 Dec; 18(6):901-6. PubMed ID: 6529531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the onset of H1-antagonism with acrivastine and terfenadine by histamine bronchial challenge in volunteers.
    Rolan PE; Adams J; Posner J
    J Int Med Res; 1989; 17 Suppl 2():35B-39B. PubMed ID: 2570000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acrivastine--an evaluation of initial and peak activity in human skin.
    Marks P; Manna VK; Gibson JR
    J Int Med Res; 1989; 17 Suppl 2():3B-8B. PubMed ID: 2569999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An investigation of the H1-receptor antagonist triprolidine: pharmacokinetics and antihistaminic effects.
    Simons KJ; Singh M; Gillespie CA; Simons FE
    J Allergy Clin Immunol; 1986 Feb; 77(2):326-30. PubMed ID: 3944383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical experience with acrivastine--a new antihistamine.
    J Int Med Res; 1989; 17 Suppl 2():1B-68B. PubMed ID: 2569994
    [No Abstract]   [Full Text] [Related]  

  • 10. Acrivastine: a review of its dermatopharmacology and clinical activity.
    Gibson JR; Manna VK; Salisbury J
    J Int Med Res; 1989; 17 Suppl 2():28B-34B. PubMed ID: 2475374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simultaneous determination of triprolidine and pseudoephedrine in human plasma by liquid chromatography-ion trap mass spectrometry.
    Shakya AK; Arafat TA; Abuawwad AN; Melhim M; Al-Ghani J; Yacoub MJ
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Dec; 877(32):4071-8. PubMed ID: 19926351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disposition of acrivastine in the male beagle dog.
    McNulty MJ; Deal DL; Nelson FR; Weller S; Chandrasurin P; Shockcor J; Findlay JW
    Drug Metab Dispos; 1992; 20(5):679-87. PubMed ID: 1358572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The histamine H1-receptor antagonist binding site. Part I: Active conformation of cyproheptadine.
    van Drooge MJ; Donné-op den Kelder GM; Timmerman H
    J Comput Aided Mol Des; 1991 Aug; 5(4):357-70. PubMed ID: 1686618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The onset of effect of the H1-antagonist acrivastine ("Semprex") assessed by histamine bronchial challenge in volunteers.
    Rolan PE; Phillips S; Adams J; Posner J
    Eur J Clin Pharmacol; 1990; 39(3):311-3. PubMed ID: 1979541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acrivastine in allergic rhinitis: a review of clinical experience.
    Bojkowski CJ; Gibbs TG; Hellstern KH; Major EW; Mullinger B
    J Int Med Res; 1989; 17 Suppl 2():54B-68B. PubMed ID: 2570003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of acrivastine versus chlorpheniramine in the treatment of chronic idiopathic urticaria.
    Gale AE; Harvey SG; Calthrop JG; Gibson JR
    J Int Med Res; 1989; 17 Suppl 2():25B-27B. PubMed ID: 2569998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutational analysis of the antagonist-binding site of the histamine H(1) receptor.
    Wieland K; Laak AM; Smit MJ; Kühne R; Timmerman H; Leurs R
    J Biol Chem; 1999 Oct; 274(42):29994-30000. PubMed ID: 10514483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Acrivastine--a new antihistaminic].
    Bindslev-Jensen C; Thestrup-Pedersen K
    Ugeskr Laeger; 1990 Jul; 152(28):2062-3. PubMed ID: 1973315
    [No Abstract]   [Full Text] [Related]  

  • 19. P-glycoprotein limits the brain penetration of nonsedating but not sedating H1-antagonists.
    Chen C; Hanson E; Watson JW; Lee JS
    Drug Metab Dispos; 2003 Mar; 31(3):312-8. PubMed ID: 12584158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acrivastine in seasonal allergic rhinitis: two randomized crossover studies to evaluate efficacy and safety.
    Gibbs TG; Irander K; Salo OP
    J Int Med Res; 1988; 16(6):413-9. PubMed ID: 2906886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.